Phase 1 EBV-Positive Lymphoma Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

EBV-AST Cell Injection for EBV-Associated Lymphoproliferative Disorders

Epstein-Barr Virus-Associated Lymphoproliferative DisordersEBV-Positive Lymphoma

Daihong Liu18 enrolled1 locationNCT07450391

Completed

Phase 1

Epstein-Barr Virus (EBV) -specific T cells as therapy for relapsed / refractory EBV-positive lymphomas

Relapsed or refractory EBV-positive lymphoma

Queensland Institute of Medical Research (QIMR)20 enrolled1 locationACTRN12608000521325